Synnovation Therapeutics
David Butera has extensive experience in business development within the biotechnology and pharmaceutical sectors. Currently serving as SVP of Business Development at Synnovation Therapeutics, David has held key positions at Incyte, including Executive Director, Senior Director, and Director of Business Development. Prior to this, David was a Director at Campbell Alliance and founded Empire BioDiscovery, LLC. Additionally, David held the role of VP of Business Development at Paramount BioSciences, showcasing a strong track record of leadership and strategic growth in the industry.
This person is not in any teams
Synnovation Therapeutics
Synnovation Therapeutics is a precision oncology company focused on small molecule therapies optimized to target key driver mechanisms in cancers.It is dedicated to the discovery and development of therapeutics that can improve the lives of people with cancer. Leveraging its deep expertise in medicinal chemistry, cancer biology, andpatient-focused precision medicine, it builds a diverse pipeline of novel small molecule targeted therapies. It aims to efficiently advance these agents into clinical trials with the goal of transforming cancer patient care.